COVID-19: EU Dexamethasone Taw Filing Pulled

 
• By Neena Brizmohun

The withdrawal of the marketing authorization application for Dexamethasone Taw as a treatment for COVID-19 patients was revealed today in the January meeting agenda of the European Medicines Agency’s human medicines committee, the CHMP.

Lab_Covid19_Tube
Dexamethasone last year emerged as a promising treatment for COVID-19 • Source: Shutterstock

More from Europe

More from Geography